Ignite Creation Date:
2025-12-24 @ 4:26 PM
Ignite Modification Date:
2026-01-05 @ 5:49 PM
Study NCT ID:
NCT03391466
Status:
COMPLETED
Last Update Posted:
2025-12-01
First Post:
2017-12-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Effectiveness of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma
Sponsor:
Kite, A Gilead Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-01-25
Start Date Type:
ACTUAL
Primary Completion Date:
2021-03-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-11-25
Completion Date Type:
ACTUAL
First Submit Date:
2017-12-21
First Submit QC Date:
None
Study First Post Date:
2018-01-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-12-20
Results First Submit QC Date:
None
Results First Post Date:
2024-03-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-11
Last Update Post Date:
2025-12-01
Last Update Post Date Type:
ESTIMATED